Sort
82,697 grants matching “vaccine development”
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$908,642Joshua Aiden Hill · Fred Hutchinson Cancer Center · U01 · FY2022 · CA
Immune Correlates of Protection from TB
$908,608Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2019 · AI
Multivalent Vaccine for Viral Hemorrhagic Fever
$908,442Thomas William Geisbert · University Of Texas Med Br Galveston · U01 · FY2010 · AI
Multivalent DNA vaccine-mediated protection against Tuberculosis
$908,439David B. Weiner · Wistar Institute · R01 · FY2021 · AI
Optimizing Oral Pediatric HIV Vaccines to Prevent Breast Milk Transmission
$908,245Kristina Abel · Univ Of North Carolina Chapel Hill · R01 · FY2016 · DE
The Generation and Maintenance of Human Memory B Cells
$908,236Susan Pierce · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Development of NHP Models for Infectious Pathogens of Man
$908,201Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Defining Drivers of HPV-associated Carcinogenesis
$908,100Paul F Lambert · University Of Wisconsin-Madison · R35 · FY2023 · CA
THE TEDDY STUDY - COLORADO CLINICAL CENTER
$907,793Marian J. Rewers · University Of Colorado Denver · U01 · FY2012 · DK
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$907,746David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
CD180 targeted immunotherapeutic for chronic HBV in HIV infected patients
$907,661Deborah L. Fuller · University Of Washington · R56 · FY2019 · AI
Task 10/D13 Efficacy of Select Antibiotics Against Pneumonic Plague in NHPs
$907,645Mary Bruce · Battelle Memorial Institute · N01 · FY2009 · AI
Novel Concepts for the Eradication of HIV
$907,484Rafick-Pierre Sekaly · Vgti Florida · DP1 · FY2011 · DA
Novel Concepts for the Eradication of HIV
$907,484Rafick-Pierre Sekaly · Vgti Florida · DP1 · FY2012 · DA
Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig
$907,386Michael David Alpert · Emmune, Inc · R44 · FY2022 · AI
Core B: GMP Cell and RNA Manufacturing
$907,314Bruce L. Levine · University Of Pennsylvania · P01 · FY2018 · CA
HIV-1 Fusion Peptide-directed Vaccine Design Using Virus-like Particles
$907,275Rui Kong · Emory University · R01 · FY2022 · AI
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles
$907,227Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2023 · AI
Vascular macrophages and T cells in atherosclerosis
$907,152Klaus F. Ley · La Jolla Institute For Immunology · R35 · FY2021 · HL
Cooperative Center for the study of HCV antibody responses and vaccine antigens
$907,122Mansun Law · Scripps Research Institute, The · U19 · FY2019 · AI
DCP - COPTRG - SELECT/PCPT
$907,044Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2023 · CA
STING agonist-expressing BCG for bladder cancer
$907,018Todd Wallach · Oncosting Llc · R44 · FY2022 · CA
Vascular macrophages and T cells in atherosclerosis
$906,991Klaus F. Ley · La Jolla Institute For Immunology · R35 · FY2020 · HL
NIH: Spatial Models of Intrahepatic Hepatitis Virus Propagation in Humans
$906,964Ruy M Ribeiro · Triad National Security, Llc · R01 · FY2023 · AI
Alphavirus Vaccines for Biodefense
$906,932Scott C Weaver · University Of Texas Med Br Galveston · U54 · FY2012 · AI